Oppenheimer Maintains Outperform on Teladoc Health, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on Teladoc Health (NYSE:TDOC), but lowered the price target from $35 to $26.
October 25, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teladoc Health's price target has been lowered from $35 to $26 by Oppenheimer, though the Outperform rating is maintained.
The lowering of the price target by Oppenheimer indicates a potential decrease in the short-term value of Teladoc Health's stock. However, the maintenance of the Outperform rating suggests that the company is still expected to perform well relative to its peers.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100